📰 Ionis Core News
Ionis Core News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ionis Core. Real-time updates on events, politics, business and more.
June 7, 2023
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) shares gapped down prior to trading on Wednesday . The stock had previously closed at $43.33, but opened at $40.49. Ionis Pharmaceuticals shares last traded at $41.18, with a volume of 334,112 shares changing hands. Wall Street Analyst Weigh In A number of research firms have recently commented […]
June 6, 2023
Nikko Asset Management Americas Inc. decreased its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) by 23.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 336,732 shares of the company’s stock after selling 100,444 shares during the quarter. Nikko […]
June 6, 2023
Nikko Asset Management Americas Inc. lessened its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) by 23.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 336,732 shares of the company’s stock after selling 100,444 shares during […]
May 26, 2023
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) has been given a consensus recommendation of “Hold” by the fourteen ratings firms that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, four have given a hold rating and five have assigned a buy rating to the company. […]
May 26, 2023
M28 Capital Management LP bought a new stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) during the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 126,300 shares of the company’s stock, valued at approximately $4,770,000. Ionis Pharmaceuticals makes up 4.5% of M28 Capital Management LP’s holdings, making the stock its 6th largest […]
May 25, 2023
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) EVP Patrick R. O’neil sold 1,527 shares of the company’s stock in a transaction dated Wednesday, May 24th. The stock was sold at an average price of $41.70, for a total transaction of $63,675.90. Following the sale, the executive vice president now directly owns 40,355 shares in the […]
May 24, 2023
Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) have been given a consensus rating of “Hold” by the fourteen research firms that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, four have given a hold recommendation and five have assigned a buy recommendation to the […]
May 22, 2023
StockNews.com started coverage on shares of Ionis Pharmaceuticals (NASDAQ:IONS – Get Rating) in a research report released on Thursday morning. The firm issued a hold rating on the stock. Several other research firms also recently weighed in on IONS. Sanford C. Bernstein initiated coverage on shares of Ionis Pharmaceuticals in a research note on Tuesday, […]
May 21, 2023
MQS Management LLC acquired a new stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 6,547 shares of the company’s stock, valued at approximately $247,000. A number of other institutional investors and hedge […]
May 17, 2023
First Trust Advisors LP trimmed its position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) by 14.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,780,933 shares of the company’s stock after selling 296,327 shares during the quarter. […]